INS and pancreatic neuroendocrine tumor: However, the expression of miR-204 was previously reported as restricted to insulinomas in pancreatic endocrine tumors (PET)27 and enriched in β cells compared to α cells in purified pancreatic islets28, suggesting a potential role in either β cell differentiation or insulin expression regulation or both.